G1 Therapeutics Inc (NQ: GTHX )
7.110
+0.010
(+0.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Press Releases about G1 Therapeutics Inc
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
![](https://mms.businesswire.com/media/20240809936863/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://mms.businesswire.com/media/20240807674471/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
Pharmacosmos Group to Acquire G1 Therapeutics
August 07, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
From G1 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights
November 01, 2023
From G1 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
From G1 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png)
Black Diamond Therapeutics Announces CEO Transition
September 18, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
![](https://ml.globenewswire.com/media/2cdc354f-0f17-4fb5-a670-1e03222cbbf3/small/g1-logo-2022-reg-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.